| Identification | More | [Name]
N-Cbz-L-Isoleucine | [CAS]
3160-59-6 | [Synonyms]
BENZYLOXYCARBONYL-L-ISOLEUCINE
CBZ-ILE-OH
CBZ-L-ILE-OH
CBZ-L-ISOLEUCINE
N-ALPHA-BENZYLOXYCARBONYL-L-ISOLEUCINE
N-ALPHA-CARBOBENZOXY-L-ISOLEUCINE
N-ALPHA-CBZ-L-ISOLEUCINE
N-CARBOBENZOXY-L-ISOLEUCINE
N-CARBOBENZYLOXY-L-ISOLEUCINE
N-CBZ-L-ISOLEUCINE
N-CBZ-L-ISOLEUCINE-OH
Z-ILE-OH
Z-L-ILE-OH
Z-L-ISOLEUCINE
Z-Ile-OH dicyclohexylamine salt
CBZ-L-Isoleucine-OH
N-Benzyloxycarbonyl-L-isoleucine~Z-Ile-OH
N-CBZ-L-ISOLEUCINE FREE ACID
N-Cbz-L-isoleucine,98+%
Z-ILE | [EINECS(EC#)]
221-611-0 | [Molecular Formula]
C14H19NO4 | [MDL Number]
MFCD00027064 | [Molecular Weight]
265.3 | [MOL File]
3160-59-6.mol |
| Chemical Properties | Back Directory | [Appearance]
white to yellowish weak solid | [Melting point ]
52-54 °C(lit.) | [alpha ]
7 º (c=6, EtOH) | [Boiling point ]
408.52°C (rough estimate) | [density ]
1.1356 (rough estimate) | [refractive index ]
6.5 ° (C=6, EtOH) | [storage temp. ]
2-8°C
| [solubility ]
DMSO (Slightly), Ethanol (Sparingly), Methanol (Sparingly) | [form ]
Off-White Semi-Solid | [pka]
4.02±0.22(Predicted) | [color ]
White or Colorless to Almost white or Almost colorless | [optical activity]
[α]20/D +6.0°, c = 6 in ethanol | [BRN ]
4189486 | [CAS DataBase Reference]
3160-59-6(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xn | [Risk Statements ]
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed .
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S24/25:Avoid contact with skin and eyes .
S36:Wear suitable protective clothing .
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . | [WGK Germany ]
3
| [HS Code ]
29242990 |
| Hazard Information | Back Directory | [Chemical Properties]
white to yellowish weak solid | [Uses]
N-Cbz-L-isoleucine is an N-Cbz-protected form of L-Isoleucine (I820175). L-Isoleucine is classified as an essential amino acid, and is also a tumour promoter of bladder cancer in rats. | [reaction suitability]
reaction type: solution phase peptide synthesis |
|
|